Patient-reported outcomes: Which ones are most relevant? by Lieshout, E.M.M. (Esther) van & Wijffels, M.M.E. (Mathieu)
ARTICLE IN PRESS 
JID: JINJ [m5G; November 7, 2019;16:59 ] 
Injury xxx (xxxx) xxx 
Contents lists available at ScienceDirect 
Injury 
journal homepage: www.elsevier.com/locate/injury 
Patient-reported outcomes: Which ones are most relevant? 
Esther M.M. Van Lieshout ∗, Mathieu M.E. Wijffels 
Trauma Research Unit Department of Surgery, Erasmus MC, University Medical Center Rotterdam, 30 0 0 CA Rotterdam, P.O. Box 2040, The Netherlands 
a r t i c l e i n f o 
Article history: 
Accepted 22 October 2019 








a b s t r a c t 
The use of patient-reported outcome measures (PROs) in research and clinical use in orthopedic trauma 
surgery has increased dramatically over the past decades, and this trend will continue in the future. 
This review aimed to provide insight into the way PROs can best be identified, reviewed, selected, and 
used in orthopedic trauma studies and patient care. Selection of instruments for a specific (research) 
question starts with a systematic literature review for identifying the mostly used instruments. From this 
list, the instruments that are most suitable for the intended use are selected. Readability, usability, and 
costs should be considered at this stage. For the selected instruments, the next step is to search the 
literature systematically in order to determine if the measurement properties of these instruments meet 
the quality standard as outlined by the COSMIN group. Instruments need to be valid for the targeted 
condition, intervention as well as population. If not available in the primary language of the targeted 
population, the instrument requires translation according to a state of the art procedure and validation 
in the new language. Reporting guidelines like the SPIRIT-PRO and CONSORT-PRO are available in order 
to guide the reporting of PROs in study protocol and outcome reports, respectively. Using Core Outcome 
Sets improves the validity of results of clinical research and increases the feasibility of conducting meta- 
analyses. If the standards and procedures as outlined above are used, the use of PROs will contribute to 
improved patient care and clinical research. 






































Outcome in orthopedic pathology was traditionally determined
ased upon clinical data such as radiographic healing, rate of com-
lications or secondary interventions, or range of motion (ROM).
rofessionals considered these data as objective. The patient per-
pective of treatment success (or failure) was not included in those
utcomes. In the past decades, the use of the so-called Patient-
eported Outcomes (PROs) has increased drastically. This mimics
he evolution from a paternalistic doctor towards shared decision
aking in daily practice; the patients opinion becomes more im-
ortant. PROs are also referred to as subjective outcomes, ‘soft’
utcomes, or self-report measures. 
PROs are generally defined as ‘any report of the status of a pa-
ient’s health condition that comes directly from the patient, with-
ut interpretation of the patient’s response by a clinician or anyone
lse’ [1] . They include, among others, perceptions and opinions on
ymptoms, functioning, health–related quality of life (HRQoL), and
atisfaction. PROs are increasingly integrated in clinical research,∗ Corresponding author. 
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nd quality control of patient care is noted [2] . 
Most objective outcome measures are subject to interrater dis-
greement and often do not provide definitive answers about
hether an intervention is useful from a patient’s perspective [3] .
lso, objective outcome measures may correlate poorly with a
atient’s perspective of his/her own feelings of wellness. Well-
esigned and rigorously tested PROs may be better validated and
ave greater reproducibility than objective outcomes [4] and even
ore importantly have more practical relevance for the patient. 
This review aimed to provide a strategy to identify, select, and
se PROs in orthopedic trauma studies and patient care. In addi-
ion to an overview of different types of PROs and their intended
se, the selection process, requirements regarding quality and lan-
uage, and reporting guidelines are discussed. 
ypes of PROs and their use 
In general, PROs can be generic or condition-specific. Generic
ROs assess the impact of musculoskeletal conditions on the over-
ll health and well-being of a patient, and were designed for use in
 broad range of conditions or interventions [5] . They often mea-
ure health-related quality of life (HR-QoL). HR-QoL is how a per-
on’s health affects his or her ability to carry out normal socialtient reported outcomes: Which ones are most relevant? Injury, 
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o  and physical activities. Examples of commonly used HR-QoL instru-
ments are the EuroQoL-5 D (EQ-5 D) [ 6 , 7 ], Short Form-36 (SF-36)
or its shorter variant the Short Form-12 (SF-12) [ 8 , 9 ], and the Short
Musculoskeletal Functional Assessment (SMFA) [10] . Generic PROs
generally have favorable measurement properties, and can be use-
ful for drawing comparisons about patient-reported health states
across groups with varying clinical conditions [11] . However, the
use of generic PROs in the outcome assessment of musculoskeletal
conditions and interventions is sometimes questioned, as they fail
to capture condition-specific functional outcomes. An exception to
this is the SMFA, which has demonstrated good validity and con-
tains questions related to musculoskeletal complaints [10] . The EQ-
5 D has been advised as instrument of choice for health-economic
evaluation in musculoskeletal research [ 12 , 13 ]. 
As opposed to generic PROs, region-specific (or anatomical site-
specific) and condition-specific PROs claim to assess both symp-
toms and functional status in patient groups with specific mus-
culoskeletal pathology. These PROs are targeted at specific injuries
( e.g. , Achilles tendon Total Rupture Score for Achilles tendon rup-
tures) [14] , treatments ( e.g. Western Ontario McMaster University
Osteoarthritis Index (WOMAC) for patients with osteoarthritis who
had arthroplasty of the knee or hip) [15] , or anatomic regions ( e.g. ,
Disabilities of the Arm, Shoulder and Hand (DASH) and the Lower
Extremity Functional Score (LEFS) for all sorts of injuries and con-
ditions of the upper extremity and lower extremity, respectively
[ 16 , 17 ]. Anatomic region-specific and condition-specific PROs in-
clude questions on aspects of health affected by a specific body re-
gion [18] . In theory they have great potential to evaluate domains
of physical function and health-related quality of life commonly af-
fected by the specified anatomical site [19] . Due to the focus on
specific conditions or anatomic regions, the condition-specific PROs
are often considered to be more sensitive to changes in health sta-
tus than generic PROs [20] . 
Ideally, a PRO is completed by either the patient or a repre-
sentative. However, several instruments used in musculoskeletal
research are so-called mixed clinician-based functional outcome
instruments. These combine questions answered by patients with
results from physical examination or clinical tests performed by
an outcome assessor. Examples of such mixed instruments are the
Harris Hip Score [21] and the Constant–Murley score [22] , which
require range of motion measurements. Other mixed PROs may
also include evaluation of the gait pattern, strength, or stability.
Scoring systems that include physical examination or clinical tests
are more prone to interobserver variability. 
Poolman et al. recommended not to use mixed clinical and
functional outcome instruments because of, among others, the risk
of interobserver variability in the clinician-reported part of the
instrument, [20] . They supported their recommendation by stat-
ing that validated outcome instruments that provide reproducible
results are available. Poolman et al. instead encourage to use
condition-specific instruments when available, as they are more
sensitive to change. 
Quality criteria for PROs 
The question which PRO is the best is not easy to answer. It de-
pends, among others, on the research question, the population of
interest, the setting ( e.g. , research or patient care), and the infras-
tructure ( e.g. , paper of electronic versions). Similar as any outcome
used in patient-centered outcomes research, PROs should meet the
required quality standards. 
The COSMIN checklist (COnsensus-based Standards for the se-
lection of health status Measurement INstruments) was developed
in an international Delphi study in order to evaluate the method-
ological quality of health status questionnaires [23] . These mea-
surement properties include: content validity, internal consistency,Please cite this article as: E.M.M. Van Lieshout and M.M.E. Wijffels, Pa
https://doi.org/10.1016/j.injury.2019.10.073 riterion validity, construct validity, reproducibility (consisting of
greement and reliability), responsiveness (also referred to as lon-
itudinal validity), floor and ceiling effects, and interpretability
24] . Table 1 describes these quality criteria in more detail and lists
he criterion for positive rating for each of the measurement prop-
rties [24] . 
A measurement tool is considered to be valid when it actually
easures what it proposes to measure [24] . A poor quality PRO
sed in effectiveness studies may, for example, lead to unreliable
nd misleading results of the study, potentially resulting in harm
o the patient or inappropriate use of resources. Any existing and
ewly developed PRO must have adequate measurement proper-
ies to detect small but relevant treatment effects or changes in
ndividual and groups of patients [23-25] . 
ther important properties 
Another important requirement is that the PRO is comprehen-
ive for all patients (or healthy volunteers, as applicable). El-Daly
t al. investigated the readability of 59 commonly used orthopedic-
pecific PROs that were available in English [26] . The Flesch Read-
ng Ease Score (FRES) was determined; the authors consider a
core of 79 points and over (out of 100 points), indicative for good
eadability by the average UK adult. They found that the mean
core for all PROs investigated was 55 points (range 0–93), cor-
esponding to text best understood by 16- to 18-year-old students.
even of the 59 PROs had a FRES score between 79 and 93 points,
orresponding to text that can be understood by the average UK
dult. These included the generic PRO SF-36 [8] and the condition-
pecific PROs Owestry Low Back Pain Score [27] , the Lysholm Knee
core [28] , and Modified Mayo Wrist Score [29] . The authors found
hat a surprising number of PROs were likely to be unreadable and
otentially incomprehensible to most patients asked to complete
hem. 
inding and selecting the most appropriate PROs 
Identifying and selecting the best PROs for your clinical re-
earch or monitoring of patients in clinical practice is a delicate
rocess. The first step is to develop a detailed research question.
ased on that, the next steps are (2) to determine what domains
r constructs you want to measure ( e.g. , pain, physical function, or
uality of life); (3) what population you aim to include ( e.g. , pa-
ients who have undergone a specific intervention or have a spe-
ific diagnosis); (4) to determine if an outcome measure exists,
hat captures all these domains for these patients; (5) to evaluate
he psychometric evidence for the outcome measure(s) identified;
nd finally if the instrument is usable. Usability concerns items like
he test burden, the time it takes to complete the questionnaire,
hether or not the questionnaire can be used free of charge, and
hether or not the scores are meaningful. 
Identifying and selecting PROs typically starts with two sys-
ematic (literature) reviews. For a complete overview, the searches
re best conducted in online general databases such as MEDLINE,
ochrane Library, EMBASE, and topic-specific databases such as the
OSMIN database of systematic reviews of measurement instru-
ents ( http://database.cosmin.nl/ ). 
In the first review, the available literature is searched for PROs
hat are commonly used in research focusing on injury or treat-
ent of interest. From the resulting list of instruments, expe-
ienced musculoskeletal clinical researchers can identify which
nstruments would be the most suitable for evaluating the inter-
ention under investigation and the targeted patient population. 
Just because an instrument has been used frequently in previ-
us studies does not guarantee its quality. The PROs used in yourtient reported outcomes: Which ones are most relevant? Injury, 
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Table 1 
Definitions and quality criteria for measurement properties of health status instrument, according to the COSMIN checklist [23] . 
Property Definition Quality criterion for positive rating ∗
Content validity The extent to which the domain of interest is comprehensively 
sampled by the items in the questionnaire 
A clear description is provided of the measurement aim, the 
target population, the concepts that are being measured, and 
the item selection AND target population and (investigators 
OR experts) were involved in item selection 
Internal consistency The extent to which items in a (sub)scale are intercorrelated, thus 
measuring the same construct 
Factor analyses performed on adequate sample size (7 ∗ # 
items and ≥100) AND Cronbach’s alpha(s) calculated per 
dimension AND Cronbach’s alpha(s) between 0.70 and 0.95 
Criterion validity The extent to which scores on a particular questionnaire relate to a 
gold standard §
Convincing arguments that gold standard is ’‘gold’’ AND 
correlation with gold standard ≥0.70 
Construct validity The extent to which scores on a particular questionnaire relate to 
other measures in a manner that is consistent with theoretically 
derived hypotheses concerning the concepts that are being measured 
Specific hypotheses were formulated AND at least 75% of the 
results are in accordance with these hypotheses 
Reproducibility The degree to which repeated measurements (test-retest) in steady 
populations provide similar answers 
Agreement The extent to which the scores on repeated measures are close to 
each other (absolute measurement error) 
MIC < SDC OR MIC outside the LOA OR convincing 
arguments that agreement is acceptable 
Reliability The extent to which patients can be distinguished from each other, 
despite measurement errors (relative measurement error) 
ICC or weighted Kappa ≥ 0.70 
Responsiveness 
(longitudinal validity) 
The ability of a questionnaire to detect clinically important changes 
over time 
SDC or SDC < MIC OR MIC outside the LOA OR RR > 1.96 OR 
AUC ≥ 0.70 
Floor and ceiling 
effects 
The number of respondents who achieved the lowest or highest 
possible score 
≤ 15% of the respondents achieved the highest or lowest 
possible scores 
Interpretability The degree to which one can assign qualitative meaning to 
quantitative scores 
Mean and SD scores presented of at least four relevant 
subgroups of patients and MIC defined 
MIC, Minimal Important Change; SDC, Smallest Detectable Change; LOA, Limits of Agreement; ICC, Intraclass correlation; SD, standard deviation. 
∗ The criteria for positive rating are shown. Further details on indeterminate and negative ratings are described in the original manuscript [23] . 










































































p  esearch should meet the COSMIN standards for the targeted inter-
ention and study population. The use of poor quality instruments
ay result in biased or unreliable effect estimates, and can thus
otentially harm patients, mislead decision-makers relying on this
vidence, and waste resources. 
After identifying the PROs of interest, the second systematic lit-
rature review is aimed to make an overview of the measurement
roperties of these PROs. Using the COSMIN checklist, each mea-
urement property is rated as positive, indeterminate (unclear from
hat is reported), or negative. If no information for a property is
vailable in the literature, a rating of zero is given to indicate no
vidence. If necessary, new primary research may be needed to fo-
us on areas where the measure is either flawed or where no ev-
dence is available. If none of the available PROs be valid, reliable,
nd responsive, development of a new PRO may be considered. De-
eloping a new PRO is time-consuming and may easily take more
han a year to complete or more depending on the complexity. Af-
er identifying a detailed aim of the instrument and the target pop-
lation, it involves a stepwise approach that includes the following
teps; (1) item generation (based on input from focus groups, lit-
rature, and a Delphi consensus process); (2) constructing a pilot
uestionnaire; (3) testing the pilot questionnaire in a sample of the
arget group (for reliability, validity, and ease of understanding);
4) generating a revised pilot questionnaire with subsequent test-
ng in another sample of the target group; (5) eliminating items
hat perform poorly (mainly based upon reliability statistics); and
6) retesting the final questionnaire to determine all measurement
roperties as shown in Table 1 [30] . 
Many systematic reviews on the methodological quality of PROs
re already available. Weel et al. evaluated Dutch foot-and ankle
ROs [31] and reported that the Foot Function Index (FFI) and the
oot and Ankle Outcome Score (FAOS) [31] are considered the best
nstruments for foot and ankle complaints. Dacombe et al. con-
ucted a systematic review on PROs for traumatic injuries to the
and and wrist used in randomized controlled trials [32] . The most
ommonly used PROs were the Disabilities of the Arm, Shoulder
nd Hand (DASH) questionnaire [16] , Patient-Rated Wrist Evalua-
ion (PRWE) [33] , Gartland and Werley score [34] , Michigan HandPlease cite this article as: E.M.M. Van Lieshout and M.M.E. Wijffels, Pa
https://doi.org/10.1016/j.injury.2019.10.073 utcomes score [35] , Mayo Wrist Score [29] , and Short Form-36
8] . Of these, only the DASH and PRWE had evidence of reliabil-
ty, validity, and responsiveness in patients with traumatic injuries
o the hand and wrist. The other PROs either had incomplete evi-
ence or evidence was gathered in a nontraumatic population [32] .
ystematic reviews of the measurement properties are also avail-
ble for other PROs used in orthopedic trauma, including the knee
36] , total knee arthroplasty [37] , anterior cruciate ligament in-
uries [38] , total hip arthroplasty [39] , upper extremity following
rauma [40] , elbow injuries [41] , hand injuries [ 42 , 43 ] and many
ore musculoskeletal disorders and conditions [2] . 
ranslation and cross-cultural adaptation of PROs 
PROs are typically developed in one language, and subsequently
ranslated in to other languages as needed. It is not sufficient to
imply translate a previously validated instrument [44] . The Amer-
can Academy of Orthopaedic Surgeons has adopted the Guideline
or Cross Cultural Adaptation of Self-Report Measures, which states
hat translation and cultural adaptation is best done using a 5-step
pproach [ 45 , 46 ]. In step 1, two native speakers of the targeted lan-
uage will individually translate the questionnaire. In step 2, syn-
hesis , the translators and a panel of experts make combine the
wo translations into one. In step 3, the new version is translated
ack into English independently by two persons, native to the orig-
nal language but highly experienced in the targeted language. In
tep 4, all translators of step 1 and 3 as well as a panel of experts
ombine the two back translated versions into one, and judge if
his matches the original questionnaire. If necessary, adjustments
o the new language version are made. This results in the (pre-
final version that is tested in step 5. The translated instrument
eeds to be revalidated before it can be applied in clinical or re-
earch settings. 
Patients in different countries may respond differently to cer-
ain questions, irrespective of whether or not they speak the same
anguage. Words can have subtle different meanings in different
eographic locations. Therefore, it is very important to consider the
opulation on which the outcome instrument was originally testedtient reported outcomes: Which ones are most relevant? Injury, 
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g  [47] . If not properly validated in the population of interest, a vali-
dation study may be needed. 
Reporting guidelines for PROs in study protocols and peer-reviewed 
manuscripts 
Clinical studies that include PROs usually do not report any in-
formation on the instruments’ measurement properties. Likewise,
there is heterogeneity in data reporting across studies, both in
the way the data are reported and in completeness of reporting
( e.g. , reported means may be inappropriate, and ranges are re-
ported instead of standard deviations). Several reporting guidelines
have been developed ( http://www.equator-network.org/library/ ). A
15-item extension of the Standard Protocol Items – Recommenda-
tions for Interventional Trials (SPIRIT-PRO) was recently developed
in order to guide the reporting of PROs in clinical trial protocols
[48] . Similarly, a 5-item extension of the COnsolidated Standards
Of Reporting Trials (CONSORT) for PROs was developed in order
to guide the reporting of PROs used as primary or secondary out-
come measures in randomized clinical trials (CONSORT-PRO) [49] .
A task force of the International Society of Quality of Life (ISO-
QOL) Research developed reporting standards for HRQOL outcomes
in RCTs. [50] . In addition, ISOQOL developed a set of minimum
standards for the design and selection of PROs for use in patient-
centered outcomes research (PCOR) and comparative effectiveness
research (CER) [51] . These may supplement the COSMIN criteria
when choosing a PRO for use in research. 
Core outcome measurement sets 
In addition to standardizing the use and reporting of PROs,
standardization of data collection for musculoskeletal research in
general is needed. In 2014, Goldhahn et al. developed a Core Out-
come Set (COS) for use in studies on distal radius fractures [52] .
A COS is an agreed upon minimum selection of outcomes that
should be measured and reported in all clinical trials for a par-
ticular health condition [53] . A COS increases the use of outcomes
that are important to patients, clinicians, and researchers. It facil-
itates comparison across studies and ensures that the outcomes
used have adequate measurement properties for their use. Finally,
it should prevent selective outcome reporting line the reporting of
only statistically significant findings. This improves the validity of
results of clinical research and increases the feasibility of conduct-
ing meta-analyses [53–55] . 
The Core Outcome Measures in Effectiveness Trials (COMET) ini-
tiative was set up to assist and support researchers in their at-
tempt to develop a COS [53] . In addition to the COS for distal ra-
dius fractures mentioned above [52] , COSs are also available for
other musculoskeletal diagnoses and interventions, including non-
specific low back pain [56] , knee pain after knee replacement [57] ,
and hip fractures [58] . The COMET database currently contains over
1100 references of planned, ongoing and completed work ( http:
//www.comet-initiative.org/ ). 
Implementation of PROs in daily clinical routine 
Individual physicians and hospitals increasingly use PROs, yet
only few countries, such as England, Sweden, and the USA, have
implemented the use of PROs on a regional or national level, [59] .
In 2004, the National Institutes of Health (NIH) in the USA de-
veloped the Patient-Reported Outcomes Measurement Information
System (PROMIS) together with an online assessment center to
provide generic measures of the most important health outcome
domains for many diseases [ 60 , 61 ]. PROMIS item banks assess
physical (physical function, fatigue, sleep disturbance, sleep relatedPlease cite this article as: E.M.M. Van Lieshout and M.M.E. Wijffels, Pa
https://doi.org/10.1016/j.injury.2019.10.073 mpairment, pain behavior, and pain interference), emotional (de-
ression, anxiety, and anger), cognitive (applied cognition-abilities
nd applied cognition general concerns), and social health (abil-
ty to participate, satisfaction with social roles and activities,
motional support, instrumental support, informational support,
nd social isolation) [60–63] . PROMIS is freely available ( www.
ssessmentcenter.net ). Through the use of Computer Adaptive Test-
ng (CAT), PROMIS health assessment data can be collected with
inimal respondent burden. 
Several initiatives to investigate clinicians’ attitudes to using
ROs in daily routine have been published (as referenced in [64] ).
nsight into the familiarity of trauma and orthopedic surgeons with
ROs and their use in daily clinical routine is limited. Joeris et
l. conducted a survey among 17,931 members of the AO Foun-
ation ( www.aofoundation.org ; 9567 trauma surgeons, 6054 spine
urgeons, and 2310 craniomaxillofacial surgeons) [64] . Of the re-
ponding trauma and orthopedic surgeons, 67% reported to be fa-
iliar with disease-specific PROs, 46% with generic PROs, yet only
7% use PROs in clinical practice. The results of this survey showed
here is consensus on the usefulness of PROs, but implementation
s limited. A majority of surgeons reported to be willing to imple-
ent PROs, if an adequate tool would be available. 
Falavigna et al. conducted a survey among AO Spine members,
imed to assess barriers for full implementation of PROs [65] . The
ain barriers to implement PROs were lack of time to administer
he questionnaires (57%) followed by lack of staff to assist in data
ollection (55%), and the long time to complete the questionnaires
46%). The authors concluded that 32% of spine surgeons did not
se PROs routinely, which was attributed to a lack of knowledge
egarding their importance, absence of reimbursement for this ex-
ra work, minimal financial support for clinical research, the cost
f implementation, and lack of concern among physicians. 
uture perspectives of PROs in musculoskeletal research and clinical 
ractice 
It is to be expected that the use of PROs in clinical practice
nd research will continue to increase. Increased use of PROs for
usculoskeletal research requires more research on the measure-
ent properties of PROMIS instruments in patients with ortho-
edic pathology. This requires rigorous systematic reviews of the
xisting evidence and new research on determining measurement
roperties of existing instruments. Developing a new PROs is only
ensible if systematic review shows an obvious gap that cannot be
olved using existing PROs. Whether or not PROMIS and Computer
dapted Testing are the ideal solution towards successful imple-
entation of PROs in clinical routine and musculoskeletal research
emains to be seen. Increased use of PROMIS requires the develop-
ent of more item banks. 
In addition to the above, developing new and implement exist-
ng Core Outcome Sets for many more musculoskeletal disorders
ill be the best approach to guide researchers. Having the same
ata for all studies on the same topic will be a huge step forward. 
onclusion 
Generic and condition-specific PROs each have their specific
ros and cons. Selection of instruments for a specific research
uestion starts with a systematic literature review for identify-
ng the mostly used instruments. From this list, the instruments
hat are most suitable for the intended use are selected. Readabil-
ty, usability, and costs are considered at this stage. For the se-
ected instruments, the literature is then searched systematically
n order to determine if the measurement properties of these in-
truments meet the quality standard as outlined by the COSMIN
roup. Instruments need to be valid for the targeted condition,tient reported outcomes: Which ones are most relevant? Injury, 
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ntervention as well as population. If not available in the primary
anguage of the targeted population, the instrument requires trans-
ation according to a state of the art procedure and validation in
he new language. Reporting guidelines like the SPIRIT-PRO and
ONSORT-PRO are available in order to guide the reporting of PROs
n study protocol and outcome reports, respectively. Using Core
utcome Sets improves the validity of results of clinical research
nd increases the feasibility of conducting meta-analyses. If the
tandards and procedures as outlined above are used, the use of
ROs will contribute to improved patient care and clinical research.
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